ADPT Adaptive Biotechnologies Corp
4,222
$3.50
$0.09
(2.51%)
| Watchers | 4,222 |
| 52-Wk Low | $2.28 |
| 52-Wk High | $9.08 |
| Market Cap | $529.05M |
| Volume | 129,003.00 |
| 52-Wk High | $9.08 |
| 52-Wk Low | $2.28 |
Adaptive Biotechnologies (NASDAQ:ADPT) PT Lowered to $5.00Zolmax • about 2 months ago
Adaptive Biotechnologies (NASDAQ:ADPT - Get Free Report) had its price objective dropped by equities research analysts at BTIG Research from $6.00 to $5.00 in a note issued to investors on Thursday...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
F5 Chief People Officer Lyra Schramm (left) and Chief Technology Officer Kunal Anand. (F5 Photos)
Seattle-based application security and delivery giant F5 announced two new executive appointments...
Announces CFO transitionSEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...
Francis Lo, chief people officer at Adaptive Biotechnologies, accepts the Workplace of the Year Award at the 2023 GeekWire Awards. (GeekWire File Photo / Kevin Lisota)
Respect. Inclusion...
SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
This is a signal that ADPT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that ADPT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...